4CIK
| plasminogen kringle 1 in complex with inhibitor | Descriptor: | 5-[(2R,4S)-2-(phenylmethyl)piperidin-4-yl]-1,2-oxazol-3-one, PLASMINOGEN | Authors: | Xue, Y, Johansson, C, Cheng, L, Pettersen, D, Gustafsson, D. | Deposit date: | 2013-12-10 | Release date: | 2014-06-18 | Last modified: | 2023-12-20 | Method: | X-RAY DIFFRACTION (1.78 Å) | Cite: | Discovery of the Fibrinolysis Inhibitor Azd6564, Acting Via Interference of a Protein-Protein Interaction. Acs Med.Chem.Lett., 5, 2014
|
|
2L0S
| Solution Structure of Human Plasminogen Kringle 3 | Descriptor: | Plasminogen | Authors: | Christen, M.T, Frank, P, Schaller, J, Llinas, M. | Deposit date: | 2010-07-15 | Release date: | 2010-08-04 | Last modified: | 2011-07-13 | Method: | SOLUTION NMR | Cite: | Human plasminogen kringle 3: solution structure, functional insights, phylogenetic landscape. Biochemistry, 49, 2010
|
|
7OCM
| K1K1H6, a potent recombinant minimal hepatocyte growth factor/scatter factor mimic | Descriptor: | 4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID, Hepatocyte growth factor alpha chain,Hepatocyte growth factor alpha chain | Authors: | de Jonge, H, de Nola, G, Gherardi, E. | Deposit date: | 2021-04-27 | Release date: | 2021-07-07 | Last modified: | 2024-02-07 | Method: | X-RAY DIFFRACTION (1.7 Å) | Cite: | Dimerization of kringle 1 domain from hepatocyte growth factor/scatter factor provides a potent MET receptor agonist. Life Sci Alliance, 5, 2022
|
|
7OCL
| |
8TCE
| |
5HPG
| |
7TNG
| Kringle domain of human Receptor Tyrosine Kinase-Like Orphan Receptor 1 (ROR1) | Descriptor: | Inactive tyrosine-protein kinase transmembrane receptor ROR1 | Authors: | Guarino, S.R, Di Bello, A, Palamini, M, Forneris, F. | Deposit date: | 2022-01-21 | Release date: | 2022-05-11 | Last modified: | 2023-10-18 | Method: | X-RAY DIFFRACTION (1.4 Å) | Cite: | Crystal structure of the kringle domain of human receptor tyrosine kinase-like orphan receptor 1 (hROR1) Acta Crystallogr.,Sect.F, 78, 2022
|
|
6RX7
| |
1TPK
| CRYSTAL STRUCTURE OF THE KRINGLE-2 DOMAIN OF TISSUE PLASMINOGEN ACTIVATOR AT 2.4-ANGSTROMS RESOLUTION | Descriptor: | CHLORIDE ION, TISSUE PLASMINOGEN ACTIVATOR | Authors: | De vos, A.M, Ultsch, M.H, Kelley, R.F, Padmanabhan, K, Tulinsky, A, Westbrook, M.L, Kossiakoff, A.A. | Deposit date: | 1991-09-24 | Release date: | 1992-07-15 | Last modified: | 2017-11-29 | Method: | X-RAY DIFFRACTION (2.4 Å) | Cite: | Crystal structure of the kringle 2 domain of tissue plasminogen activator at 2.4-A resolution. Biochemistry, 31, 1992
|
|
1URK
| SOLUTION STRUCTURE OF THE AMINO TERMINAL FRAGMENT OF UROKINASE-TYPE PLASMINOGEN ACTIVATOR | Descriptor: | PLASMINOGEN ACTIVATOR, alpha-L-fucopyranose | Authors: | Hansen, A.P, Petros, A.M, Meadows, R.P, Nettesheim, D.G, Mazar, A.P, Olejniczak, E.T, Xu, R.X, Pederson, T.M, Henkin, J, Fesik, S.W. | Deposit date: | 1994-01-10 | Release date: | 1995-05-08 | Last modified: | 2020-07-29 | Method: | SOLUTION NMR | Cite: | Solution structure of the amino-terminal fragment of urokinase-type plasminogen activator. Biochemistry, 33, 1994
|
|
3KIV
| RECOMBINANT KRINGLE IV-10/M66 VARIANT OF HUMAN APOLIPOPROTEIN(A) | Descriptor: | 6-AMINOHEXANOIC ACID, APOLIPOPROTEIN | Authors: | Mochalkin, I, Tulinsky, A, Scanu, A. | Deposit date: | 1998-09-08 | Release date: | 1999-05-18 | Last modified: | 2023-11-15 | Method: | X-RAY DIFFRACTION (1.8 Å) | Cite: | Recombinant kringle IV-10 modules of human apolipoprotein(a): structure, ligand binding modes, and biological relevance. Biochemistry, 38, 1999
|
|
1B2I
| |
2PK4
| |
5Z55
| |
8V8Z
| |
8V9B
| Lipoprotein(a) Kringle IV domain 7 - Lp(a) KIV7 in complex with LY3441732 | Descriptor: | (2S,2'S)-3,3'-[carbonylbis(azanediyl-3,1-phenylene)]bis{2-[(3R)-pyrrolidin-1-ium-3-yl]propanoate}, Apolipoprotein(a), MAGNESIUM ION, ... | Authors: | Hendle, J, Weichert, K, Sauder, J.M. | Deposit date: | 2023-12-07 | Release date: | 2024-05-08 | Last modified: | 2024-06-19 | Method: | X-RAY DIFFRACTION (1.19 Å) | Cite: | Discovery of potent small-molecule inhibitors of lipoprotein(a) formation. Nature, 629, 2024
|
|
4KIV
| |
6BA5
| |
6BAN
| |
2FEB
| NMR Solution Structure, Dynamics and Binding Properties of the Kringle IV Type 8 module of apolipoprotein(a) | Descriptor: | Apolipoprotein(a) | Authors: | Chitayat, S, Kanelis, V, Koschinsky, M.L, Smith, S.P. | Deposit date: | 2005-12-15 | Release date: | 2006-12-26 | Last modified: | 2022-03-09 | Method: | SOLUTION NMR | Cite: | Nuclear magnetic resonance (NMR) solution structure, dynamics, and binding properties of the kringle IV type 8 module of apolipoprotein(a). Biochemistry, 46, 2007
|
|
1CEA
| |
2I9A
| |
6OSV
| Potent and Selective Antitumor Antibody Targeting a Membrane-Proximal Epitope of ROR2 | Descriptor: | Antibody heavy chain variable region, Antibody light chain variable region, Tyrosine-protein kinase transmembrane receptor ROR2 | Authors: | Park, H, Rader, C. | Deposit date: | 2019-05-02 | Release date: | 2020-04-01 | Last modified: | 2020-05-13 | Method: | X-RAY DIFFRACTION (1.34 Å) | Cite: | Affinity maturation, humanization, and co-crystallization of a rabbit anti-human ROR2 monoclonal antibody for therapeutic applications. J.Biol.Chem., 295, 2020
|
|
6OSH
| Potent and Selective Antitumor Antibody Targeting a Membrane-Proximal Epitope of ROR2 | Descriptor: | Antibody Light chain variable region, Antibody heavy chain variable region, Tyrosine-protein kinase transmembrane receptor ROR2 | Authors: | Park, H, Rader, C. | Deposit date: | 2019-05-01 | Release date: | 2020-04-01 | Last modified: | 2023-10-11 | Method: | X-RAY DIFFRACTION (1.117 Å) | Cite: | Affinity maturation, humanization, and co-crystallization of a rabbit anti-human ROR2 monoclonal antibody for therapeutic applications. J.Biol.Chem., 295, 2020
|
|
6OSN
| |